Eli Lilly's weight-loss drug helps nearly 99% of patients remain diabetes-free
Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...
Business Insider12h
Eli Lilly announces results from Phase 3 SURMOUNT-1 three-year study
Eli Lilly (LLY) and Company announced detailed results from the Phase 3 SURMOUNT-1 three-year study, the longest completed study to date of tirzepatide. Weekly tirzepatide injections significantly ...
Hosted on MSN13h
Why Eli Lilly’s CEO says failing faster is essential to the company’s success
On this episode of Fortune’s Leadership Next podcast, host Diane Brady talks to Eli Lilly chair and ... many thousand PhDs at ...
Did Viking Therapeutics Just Say "Checkmate" To Eli Lilly?
Below, I'll break down what's going on at Viking and explain how the company may emerge as a competitive force in the weight ...